European Society of Gene & Cell Therapy (ESGCT)

The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional adviser to stakeholder communities and regulatory bodies in Europe.

History:
ESGCT was founded in January 1992 as the European Working Group on Human Gene Transfer and Therapy (EWGT). The Society was renamed the European Society of Gene Therapy (ESGT) in 1998. In 2007, the Society's name was changed again to ESGCT to reflect that the fields of gene and cell therapy can not be separated from one another. In 2017 ESGCT celebrated its 25th anniversary at the Annual Congress in Berlin.